AI and digital innovation & the transformation of care delivery

It goes without saying that healthcare is in the midst of a digital, AI-accelerated transformation. It is an evolution with a clear goal: to improve patient outcomes by optimising timely, precise, personalised treatment regimens. Central to that evolution is the transformation of care delivery.

As published in Digital Engineering, digital transformation in healthcare offers significant potential to enhance the quality, accessibility, and efficiency of care. However, successful implementation requires navigating several challenges, including securing buy-in from healthcare providers and decision-makers, ensuring training and adoption among clinical and administrative staff, addressing compatibility and smooth data exchange across hospital systems and technologies, and managing the financial investment required. Not to mention the necessary ongoing evolution of policy frameworks.

Through this ongoing transformation, in terms of both advisory and digital solutions, Boston Scientific has found practical ways to support hospitals with new efficiencies in how they operate and redefine the way they deliver healthcare – benefitting hospital management, healthcare delivery teams, and patients alike.

To find out more, pharmaphorum spoke with Faruk Uzman, Vice President Europe, Middle East & Africa for Healthcare Solutions & Strategy at Boston Scientific.

From reactive to predictive care

“In healthcare, and especially in healthcare delivery, AI and broader digital tools are accelerating the shift from reactive to predictive models of care,” said Uzman. “AI can support earlier diagnosis. It helps inform smarter resource allocation and helps develop personalised patient pathways, which can give physicians timely insights for their decisions. It can also support improved efficiency in healthcare delivery.”

Recent industry analyses highlight how AI is becoming a differentiator across MedTech that is elevating and expanding the ability to provide quality patient care.

In regard to the importance of integrated and insight-driven solutions at Boston Scientific, Uzman emphasized the company’s focus on minimally invasive therapies.

“Patients are showing greater interest in minimally invasive therapies as they often allow faster recovery compared to traditional treatments. Providers, from clinicians to hospital decision-makers, are also drawn to approaches that are more integrated and more resource-efficient, delivering clinical outcomes in a faster and more predictable way. Such integrated and insight-driven solutions can provide workflow efficiencies to hospitals, helping them address clinical, operational, and economic needs in a sustainable manner.”

“If you look at some of the biggest pain points in healthcare today, it’s waiting lists and access to therapies — being able to receive care at the right time,” he continued. “These innovations can help expand patient access, allowing clinicians to manage care more remotely when appropriate. For example, we have a remote patient monitoring solution for people with implanted cardiac devices. It allows care teams to remotely review device data and key clinical information, helping them identify patients who may need attention sooner and support ongoing follow-up between in-person visits.”

Digitally enabled healthcare solutions

One example of this shift is HeartLogicTM, a digital diagnostic technology designed to help clinicians identify patients who may be at increased risk of worsening heart failure. HeartLogic could predict up to 70% of cases of worsening heart failure about 34 days before an event occurs and alerts doctors, giving them time to intervene.¹ Information from the HeartLogic algorithm is transmitted via a communicator to a remote monitoring platform that allows medical teams to follow and prioritise multiple patients between in-person visits.

While heart failure can be economically challenging for hospital systems and patients given unpredictability, an observational study demonstrated a 74% reduction in hospitalisations for decompensated heart failure after activation of HeartLogic as well as a 56% reduction in hospital length of stay.^2,3

These advances reflect a broader shift toward more connected and digitally supported models of care.

Public–private partnerships and system-level healthcare solutions

Healthcare systems across Europe are under increasing financial pressure, from payers, Ministries of Health, and hospitals, which is driving a stronger focus on value. This is also accelerating interest in public–private partnerships, where the private sector can meaningfully support providers and improve system efficiency. Uzman believes there is significant untapped opportunity for public institutions to leverage these models, and that this shift is still in its early phase.

“It’s an entire continuum of healthcare delivery,” said Uzman. “From understanding market trends, to shaping solutions that address system- and hospital-level challenges, and then applying AI-enabled, remote, and digital services to support earlier intervention and better coordination across care pathways, including screening and diagnosis.”

And as for the future?

“We will continue to move toward minimally invasive therapies that improve clinical, economic, and operational outcomes,” Uzman stated. “And we will continue to advance, thanks to considered AI-enabled solutions, toward more predictive and more connected ecosystems — enabling more preventative approaches, earlier insights, and more coordinated care pathways. All of this ultimately supports better outcomes for patients.”

About the interviewee

Faruk Uzman joined Boston Scientific in 2018 and brings 25 years of experience, having held various leadership roles in healthcare strategy, commercial leadership and business development. Most recently, he played a pivotal role in establishing and leading the Healthcare Services and Commercial Excellence organisation in the Growth Emerging Markets (GEM) region. He now has an expanded role at Boston Scientific leading the Healthcare Solutions and Strategy across Europe, the Middle East and Africa (EMEA). With Uzman leading Healthcare Solutions and Strategy, Boston Scientific continues its commitment to delivering innovative solutions that address the evolving needs of healthcare systems and improve outcomes for patients and healthcare providers across the EMEA region.

About Boston Scientific

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.eu and follow us on LinkedIn.